EcoDrugPlus

Tyrosine Kinase 2

Ensembl ID : ENSMPUG00000006692
Gene Symbol: TYK2
2 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSMPUG00000013763
Gene Symbol: TIE1
2 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSMPUG00000018055
Gene Symbol: UTRN
4 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSMPUG00000012815
Gene Symbol: VEGFA
2 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSMPUG00000000419
Gene Symbol: VDR
2 Cross references
458 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSMPUG00000005154
Gene Symbol: XDH
2 Cross references
211 Possible Orthologues:

Ensembl ID : ENSMPUG00000010918
Gene Symbol: -
Cross references: -
654 Possible Orthologues:

Ensembl ID : ENSMPUG00000010954
Gene Symbol: -
Cross references: -
660 Possible Orthologues:

Ensembl ID : ENSMPUG00000011734
Gene Symbol: -
Cross references: -
297 Possible Orthologues:

Ensembl ID : ENSMPUG00000002093
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSMPUG00000012237
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSMPUG00000006022
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).